CRP and COVID-19: As the importance of JAK/STAT in the pathogenesis of COVID-19 was shown previously, baricitinib is a JAK inhibitor that leads to the inactivation of STATs and a decrease in the serum levels of IgG, IgA, IgM, and CRP.